{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:55:18Z","timestamp":1793145318875,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","award":["IEC-640\/03.11.2017"],"award-info":[{"award-number":["IEC-640\/03.11.2017"]}],"id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","award":["RP-31\/2020"],"award-info":[{"award-number":["RP-31\/2020"]}],"id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["PDF\/2017\/002764"],"award-info":[{"award-number":["PDF\/2017\/002764"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clgc.2025.102351","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:36:52Z","timestamp":1744879012000},"page":"102351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phenotypic Diversity of Immunosuppressive B Cells Associated in Urothelial Carcinoma of the Bladder"],"prefix":"10.1016","volume":"23","author":[{"given":"Karuppasamy David","family":"Raja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamima","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhjot","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlesh","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2658-3338","authenticated-orcid":false,"given":"Alpana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2025.102351_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.clgc.2025.102351_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.clgc.2025.102351_bib0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/1744666X.2015.983082","article-title":"Immunological basis in the pathogenesis and treatment of bladder cancer","volume":"11","author":"Thompson","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"9165","key":"10.1016\/j.clgc.2025.102351_bib0004","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.clgc.2025.102351_bib0005","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2025.102351_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"issue":"May","key":"10.1016\/j.clgc.2025.102351_bib0007","first-page":"1","article-title":"Immunotherapy in the treatment of urothelial bladder cancer: insights from single-cell analysis","volume":"11","author":"Zang","year":"2021","journal-title":"Front Oncol"},{"issue":"November","key":"10.1016\/j.clgc.2025.102351_bib0008","first-page":"1","article-title":"Immune responses in bladder cancer-role of Immune cell populations, prognostic factors and therapeutic implications","volume":"9","author":"Joseph","year":"2019","journal-title":"Front Oncol"},{"issue":"26","key":"10.1016\/j.clgc.2025.102351_bib0009","doi-asserted-by":"crossref","first-page":"39916","DOI":"10.18632\/oncotarget.9537","article-title":"Tumour-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical bacillus calmette-gu\u00e9rin therapy in bladder cancer","volume":"7","author":"Pichler","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.clgc.2025.102351_bib0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.clgc.2025.102351_bib0011","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-immunol-101220-015603","article-title":"B cell function in the tumour microenvironment","volume":"40","author":"Downs-Canner","year":"2022","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.clgc.2025.102351_bib0012","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumour immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-016-0145-x","article-title":"B cell regulation of the anti-tumour response and role in carcinogenesis","volume":"4","author":"Schwartz","year":"2016","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2025.102351_bib0014","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/intimm\/dxz068","article-title":"Heterogeneous subsets of B-lineage regulatory cells (Breg cells)","volume":"32","author":"Baba","year":"2019","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102351_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sji.12830","article-title":"Tumour-associated B cells in urothelial urinary bladder cancer","volume":"91","author":"Zirakzadeh","year":"2020","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102351_bib0016","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s13277-013-0717-z","article-title":"Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma","volume":"34","author":"Liang","year":"2013","journal-title":"Tumour Biology"},{"issue":"10","key":"10.1016\/j.clgc.2025.102351_bib0017","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/intimm\/dxv027","article-title":"Signals controlling the development and activity of regulatory B-lineage cells","volume":"27","author":"Baba","year":"2015","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cei\/uxac029","article-title":"Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses","volume":"209","author":"Flores-Borja","year":"2022","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0019","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1744897","article-title":"Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma","volume":"9","author":"Podojil","year":"2020","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.clgc.2025.102351_bib54","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1007\/s00432-022-04507-y","article-title":"KCMF1 regulates autophagy and ion channels\u2019 function in renal cell carcinoma: a future therapeutic target","volume":"149","author":"Singh","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"OCT","key":"10.1016\/j.clgc.2025.102351_bib0020","first-page":"1","article-title":"Challenges and opportunities for consistent classification of human b cell and plasma cell populations","volume":"10","author":"Sanz","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clgc.2025.102351_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1413067","article-title":"Mature tertiary lymphoid structures: important contributors to anti-tumour immune efficacy","volume":"15","author":"Bao","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102351_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100063","article-title":"Standardized pathology screening of mature tertiary lymphoid structures in cancers","volume":"103","author":"Vanhersecke","year":"2023","journal-title":"Lab Investig"},{"key":"10.1016\/j.clgc.2025.102351_bib0023","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-030-59038-3_17","article-title":"The tumour microenvironment of bladder cancer","volume":"1296","author":"Hatogai","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-023-03949-3","article-title":"Tumour-associated macrophages and tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis","volume":"21","author":"Koll","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00262-018-2250-9","article-title":"CD19 + tumour-infiltrating B-cells prime CD4 + T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer","volume":"68","author":"Jiang","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clgc.2025.102351_bib0026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clim.2016.12.003","article-title":"Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer","volume":"176","author":"Zirakzadeh","year":"2017","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102351_bib0027","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"Lebien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clgc.2025.102351_bib0028","series-title":"Kuby Immunology","author":"Kind","year":"2013"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0029","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imr.13016","article-title":"Memory B cells and plasma cells: the differentiative continuum of humoral immunity","volume":"303","author":"MP","year":"2021","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clgc.2025.102351_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611795","article-title":"Immunosuppressive mechanisms of regulatory B cells","volume":"12","author":"Catal\u00e1n","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-023-04151-1","article-title":"The potential crosstalk between tumour and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer","volume":"21","author":"Long","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0032","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2018.11.008","article-title":"Regulatory and effector B cells: friends or foes?","volume":"93","author":"Matsushita","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clgc.2025.102351_bib0033","article-title":"Identification of immune-related subtypes and characterization of tumour microenvironment infiltration in bladder cancer","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102351_bib0034","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7150\/ijms.42151","article-title":"Profiles of immune infiltration in bladder cancer and its clinical significance: an integrative genomic analysis","volume":"17","author":"Wu","year":"2020","journal-title":"Int J Med Sci"},{"issue":"8","key":"10.1016\/j.clgc.2025.102351_bib0035","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumours independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0036","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1172\/JCI116977","article-title":"Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein","volume":"93","author":"Levy","year":"1994","journal-title":"J Clin Investig"},{"issue":"28","key":"10.1016\/j.clgc.2025.102351_bib0037","doi-asserted-by":"crossref","first-page":"26065","DOI":"10.18632\/oncotarget.4569","article-title":"Tumour microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8\/androgen receptor (AR)\/MMPs signals","volume":"6","author":"Ou","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-024-04860-1","article-title":"Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer","volume":"22","author":"Yuan","year":"2024","journal-title":"J Transl Med"},{"issue":"November 2019","key":"10.1016\/j.clgc.2025.102351_bib0039","article-title":"Regulatory B cells in infection, inflammation, and autoimmunity","volume":"352","author":"Dasgupta","year":"2020","journal-title":"Cell Immunol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102351_bib0040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cmet.2021.05.008","article-title":"The emerging field of regulatory B cell immunometabolism","volume":"33","author":"Rosser","year":"2021","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.clgc.2025.102351_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0011258","article-title":"T cell subsets, regulatory T, regulatory B cells and proinflammatory cytokine profile in Schistosoma haematobium associated bladder cancer: first report from Upper Egypt","volume":"17","author":"Mohammed","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.clgc.2025.102351_bib0042","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/sji.12407","article-title":"Increased B regulatory phenotype in non-metastatic lymph nodes of node-positive breast cancer patients","volume":"83","author":"Mehdipour","year":"2016","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0043","doi-asserted-by":"crossref","first-page":"7","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-1.15739","article-title":"Changes in expression of TLR-4, TGF-\u03b2, INF-\u03b3, TNF-\u03b1 in cultured T24\/83 cells of invasive bladder cancer treated with cisplatin and\/or polyphenolic adjuvant melanin","volume":"43","author":"Yakovlev","year":"2021","journal-title":"Exp Oncol"},{"issue":"12","key":"10.1016\/j.clgc.2025.102351_bib0044","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ptr.3132","article-title":"Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells","volume":"24","author":"Lee","year":"2010","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.clgc.2025.102351_bib0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.coi.2018.09.012","article-title":"Natural regulatory plasma cells","volume":"55","author":"Fillatreau","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102351_bib0046","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","volume":"15","author":"Shen","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.clgc.2025.102351_bib0047","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/nm.3680","article-title":"Regulatory B cells are induced by gut microbiota\u2013driven interleukin-1\u03b2 and interleukin-6 production","volume":"20","author":"Rosser","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.clgc.2025.102351_bib0048","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fimmu.2019.01368","article-title":"APRIL induces a novel subset of IgA+ regulatory B cells that suppress inflammation via expression of IL-10 and PD-L1","volume":"10","author":"Fehres","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102351_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cti2.1270","article-title":"TGF-\u03b2-secreting regulatory B cells: unsung players in immune regulation","volume":"10","author":"Huai","year":"2021","journal-title":"Clin Transl Immunol"},{"issue":"7693","key":"10.1016\/j.clgc.2025.102351_bib0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0051","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2144669","article-title":"Chemokine switch regulated by TGF-\u03b21 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy","volume":"11","author":"Vienot","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clgc.2025.102351_bib0052","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ebiom.2019.08.012","article-title":"TGF-\u03b2-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation","volume":"47","author":"Chen","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.clgc.2025.102351_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-023-04303-3","article-title":"TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells","volume":"21","author":"Ping","year":"2023","journal-title":"J Transl Med"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:40:10Z","timestamp":1778618410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1558767325000527"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102351","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic Diversity of Immunosuppressive B Cells Associated in Urothelial Carcinoma of the Bladder","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102351"}}